Aster DM Healthcare Ltd. · NSE:ASTERDM

Aster DM Healthcare — Q3 FY2020 Earnings Presentation

32 slides from Aster DM Healthcare's earnings presentation, Feb 15, 2020

  1. Slide 1: Intimation of meeting with analysts and institutional investors

    February 15, 2020 The Secretary The Manager, Listing Department, Listing Department, BSE Limited, The National Stock Exchange of India Ltd 1st Floor, Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street, Mumbai 400001 Bandra Kurla Complex Scrip Code: 540975 Bandra (East), Mumbai 40005

  2. Slide 2: Investor Presentation – For the quarter ended 31st December 2019

    Investor Presentation – For the quarter ended 31st December 2019 1

  3. Slide 3: Disclaimer

    Disclaimer ❑ This presentation has been prepared by Aster DM Healthcare Limited (the "Company"), content of which was compiled from sources believed to be reliable for informational purposes only and are based on information regarding the Company and the economic, regulatory, market and other condit

  4. Slide 4: Aster – An Integrated Healthcare Provider Overview

    Aster – Overview Aster – An Integrated Healthcare Provider Operational and Financial Overview Strategy and Leadership 3

  5. Slide 5: Aster DM Healthcare – Business Overview

    Aster DM Healthcare – Business Overview HOSPITALS One of Largest Private CAPACITY BEDS healthcare service providers GCC: 1,111 GCC: 12 4,804 25 India: 3,693 India: 13 operating in Asia (GCC & India) PATIENT VISITS – FY20 9M Present in 8 Countries CLINICS (UAE, Saudi Arabia, Qatar, Oman, ~14.4 mn GCC

  6. Slide 6: Aster DM Healthcare – Financial Overview

    Aster DM Healthcare – Financial Overview Revenue - FY209M Revenue - FY209M India 19% Pharmacies USD 920 Mn 26% Hospitals Clinics 51% GCC 81% 23% EBITDA - FY209M EBITDA - FY209M India Pharmacies 20% 19% USD 93 Mn Clinics Hospitals GCC 25% 56% 80% Note: Assumed 1 USD = 70 INR 1. Revenue and EBITDA sho

  7. Slide 7: Geographical Footprint

    Geographical Footprint Hospitals – 12 GCC Clinics – 107 Pharmacies - 236 Hospitals - 13 Clinics - 9 INDIA United Arab Emirates Kerala Medcare Hospital, Dubai Aster Medcity, Kochi Medcare Orthopaedics and Spine Hospital Aster MIMS, Calicut Aster Hospital Mankhool Aster MIMS, Kottakkal Medcare Women &

  8. Slide 8: The Aster DM Healthcare Edge

    The Aster DM Healthcare Edge Aster DM – A Healthcare Ecosystem • Presence across hospitals, clinics & pharmacies and providing primary, secondary and tertiary/ quaternary care • Strategic and sizeable network of clinics enable patient feeder Differentiated Asset-light Business Model in GCC structure

  9. Slide 9: Aster DM Healthcare – Evolution

    Aster DM Healthcare - Evolution Building the foundations New geographies, segments Brand “Aster” was formed, private equity Robust Growth across all segments and and service offerings investment, further expansion geographies; Rapid Expansion in India 1987: Commenced 2003: Expansion to new geography

  10. Slide 10: Robust Growth Over Last 5 Years

    ROBUST GROWTH OVER LAST 5 YEARS Outpatient Count (in mn) Inpatient Count (in ’000) Aster DM - Revenue from Operations (USD Mn) 1,138 218 960 202 192 847 920 158 750 8.7 125 554 6.7 7.8 7.0 104 410 5.6 85 3.4 4.2 192 823 920 163 6.3 7.0 FY14 FY15 FY16 FY17 FY18 FY19 FY20 9M FY14 FY15 FY16 FY17 FY18 F

  11. Slide 11: Aster – An Integrated Healthcare Provider Overview

    Aster – Overview Aster – An Integrated Healthcare Provider Operational and Financial Overview Strategy and Leadership 10

  12. Slide 12: Aster – An Integrated Healthcare Provider: FY19 Operational Information

    Aster - An Integrated Healthcare Provider FY19 Operational Information 1,700+ 2,18,000+ Cardiovascular IP Discharges Surgeries ~5.6 mn 14,800+ 500+ Clinic OPD Visits General Bariatric Surgeries Surgeries Clinics $ 1 ₹6 0% 1200+ Joint 1,100+ ~ 9.6 mn Replacements Spine Surgeries Pharmacy Visits 9,600

  13. Slide 13: Aster – A Healthcare Ecosystem

    Aster – A Healthcare Ecosystem ▪ Aster, over 30 years, has created a healthcare eco-system across two geographical regions ▪ In GCC region, Aster’s primary care clinics act as the initial touch-points in the patient journey, while pharmacies and hospitals continue the care ▪ For complex tertiary car

  14. Slide 14: GCC Healthcare – Unique Traits

    GCC Healthcare – Unique Traits Healthcare market in GCC states have developed certain unique traits due to the higher expat Population (mn) and working age population Expat% -> ~80% ~70% ~45% ~30% Prevalence of Primary and Secondary Healthcare Facilities (Private Sector) 32.0 ➢ Due to lower % of old

  15. Slide 15: Aster – Awards & Service Excellence

    Aster - Awards & Service Excellence “The Sheikh Khalifa Excellence Award” JCI Accreditation Padma Shri Award (2018) Medcare Hospital Dubai, Medcare Dr. Azad Moopen, Chairman & Managing Orthopedics and Spine Hospitals, Medcare Director – Aster DM Healthcare received Women & Children Hospital,Aster Me

  16. Slide 16: Operational and Financial Overview

    Aster – Overview Aster – An Integrated Healthcare Provider Operational and Financial Overview Strategy and Leadership 15

  17. Slide 17: Revenue and Profitability Snapshot – FY20 9M

    Revenue and Profitability Snapshot – FY20 9M Revenue from Operations EBITDA (excl. Other Income) PAT (Post-NCI) USD 93 Mn USD 920 Mn USD 29 Mn USD 823 Mn USD 73 Mn 10.1% 8.9% USD 18 Mn 3.1% 2.1% FY19 9m FY20 9m FY19 9m FY20 9m FY19 9m FY20 9m ▪ Constant currency growth of Revenue, EBITDA and Adjuste

  18. Slide 18: Geography-wise Financial Snapshot

    Geography-wise Financial – Snapshot GCC INDIA CONSOLIDATED FY19 9M FY20 9M FY19 9M FY20 9M FY19 9M FY20 9M Revenue (USD) 686 Mn 744 Mn 137 Mn 176 Mn 823 Mn 920 Mn EBITDA (USD) 61 Mn 74 Mn 12 Mn 19 Mn 73 Mn 93 Mn PAT (USD) 20 Mn 28 Mn (2) Mn 0.4 Mn 18 Mn 29 Mn Notes: 1USD=70INR 1. Revenue and EBITDA

  19. Slide 19: Geography-wise Business Snapshot

    Geography-wise Business – Snapshot GCC INDIA CONSOLIDATED FY19 9M FY20 9M FY19 9M FY20 9M FY19 9M FY20 9M Total Capacity Beds 1,052 1,111 4,038 3,693 5,090 4,804 Operational Beds 872 920 2,928 2,608 3,800 3,528 ALOS (Days) 2.0 1.9 3.5 3.5 3.0 3.0 Occupancy4 57% 55% 62% 63% 61% 61% Outpatient Visits3

  20. Slide 20: Segmental Performance FY20 9M

    Segmental Performance FY20 9M India- India- GCC GCC Hospitals Unallocated GCC GCC Hospitals Unallocated FY20 9M Hospitals GCC Clinics Pharmacies & Clinics & Eliminations Total Hospitals GCC Clinics Pharmacies & Clinics & Eliminations Total No. of Business Units (#) 12 107 236 H-13, C-9 NA 377 Operat

  21. Slide 21: Vintage-wise Performance FY20 9M

    Vintage-wise Performance FY20 9M GCC Hospitals – Revenue (USD Mn) GCC Clinics – Revenue (USD Mn) India Hospitals and Clinics – Consolidated – Revenue (USD Mn)* 9 Revenue (USD Mn) 83 55 19 210 203 212 837 920 155 157 175 Established Ramp-up Total Established Ramp-up Total Established Ramp-up Total Es

  22. Slide 22: Maturity Wise Hospital Performance – GCC FY20 9M

    Maturity Wise Hospital Performance – GCC FY20 9M Key Performance indicators Revenue Maturity Hospitals Operational Beds (USD in Mn.) EBITDA ARPOBD Occupancy EBITDA % (USD in Mn.) USD1.1 18% 28% 36% 4 Mn 0-3 Years USD 55Mn 254 USD ~2,353 2% 82% 72% 62% USD40.9 Over 3 Years 8 USD 258Mn 666 USD ~2,350

  23. Slide 23: Maturity Wise Hospital Performance – India FY20 9M

    Maturity Wise Hospital Performance – India FY20 9M Key Performance indicators Revenue Maturity Hospitals Operational Beds (USD in Mn.) EBITDA ARPOBD Occupancy EBITDA % (USD in Mn.) 10% 13% 66% USD(2.3) 0-3 Years 2 USD 18Mn 331 USD ~337 Mn 90% 62% USD23.6 87% Over 3 Years 10 USD155Mn 2,277 USD ~396 M

  24. Slide 24: Financial Summary – Profitability Statement

    Financial Summary – Profitability Statement Particulars (USD mn) FY19 9M FY20 9M Grt% Revenue from operations 823 920 12% Material consumption 251 277 Doctors cost 181 206 Employee cost (excl. doctors) 168 178 Other expenses 113 123 EBITDAR 111 137 24% ▪ FY20 9M EBITDA before INDAS116 EBITDAR % 13.4

  25. Slide 25: Financial Summary – Key Financial Ratios & Debts

    Financial Summary – Key Financial Ratios & Debts India (in USD mn) As at Mar 31, 2019 As at Dec 31, 2019 Debt 52 58 Less: Cash, Bank Balance and Current Investments 18 8 Net Debt 35 50 GCC (in USD mn) As at Mar 31, 2019 As at Dec 31, 2019 Debt 330 386 Less: Cash, Bank Balance and Current Investments

  26. Slide 26: Pipeline Projects

    Pipeline Projects Expected Completion Owned / Hospitals - GCC Location Type Planned Beds Stage Year Leased/O&M Aster Hospital Sonapur, Dubai, UAE Greenfield 41 Q4 FY 2020 Construction Leased Aster Hospital Sharjah, UAE Greenfield 80 Q4 FY 2021 Construction Leased Greenfield Aster Hospital Muscat, Om

  27. Slide 27: Strategy and Leadership

    Aster – Overview Aster – An Integrated Healthcare Provider Operational and Financial Overview Strategy and Leadership 26

  28. Slide 28: ADMHL – Strategy & Outlook (1/2)

    ADMHL – Strategy & Outlook (1/2) Strengthening of hub and A comprehensive human Scalable systems Strengthening of our medical spoke model in GCC resource strategy utilizing our implementation, tightly tourism network geographical diversity and integrated with catering to future growth operations/mar

  29. Slide 29: ADMHL – Strategy & Outlook (2/2)

    ADMHL – Strategy & Outlook (2/2) Profitability growth & brand Building of brand, talent Specialized, asset-light Cost Optimization positioning using product- and capability in KSA – a growth in India mix and technology key market in GCC • Focus on margin expansion through • There is significant dema

  30. Slide 30: Leadership Team

    Aster Leadership Team Dr. Azad Moopen Dr. Harish Pillai Veneeth Purushotaman Chairman and Managing Director Chief Executive Officer – India Chief Information Officer Alisha Moopen Jobilal M. Vavachan Chief Executive Officer – Chief Executive Officer, Aster Fara Siddiqi GCC Hospitals & Clinics Pharma

  31. Slide 31: Board of Directors

    Aster Board of Directors strategy andleadership Ravi Prasad Daniel James Dr. Azad Moopen Independent Director Snyder Chairman and Managing Director Independent Director Alisha Moopen Dr Layla Mohamed Suresh M. Non-Executive Director Kumar Al-Marzooqi Independent Director Independent Director Daniel

  32. Slide 32: www.asterdmhealthcare.com

    www.asterdmhealthcare.com

Aster DM Healthcare — Q3 FY2020 Earnings Presentation on 6ix